Post-approval studies (Phase 4)Study completedNCT00808951What this trial is testingIn Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina FasoWho this might be right forMalaria Centre Muraz 440
Large-scale testing (Phase 3)Looking for participantsNCT07082205What this trial is testingMonoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital DischargeWho this might be right forMalariaSevere MalariaSevere Anaemia+1 more Liverpool School of Tropical Medicine 398
Large-scale testing (Phase 3)Looking for participantsNCT05531565What this trial is testingA 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusWho this might be right forSubacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus Biogen 450
Not applicableStudy completedNCT00341003What this trial is testingSevere Malaria and Anti-malarial Drug Resistance in CambodiaWho this might be right forSevere MalariaMalariaAntimalarial Drug Resistance National Institute of Allergy and Infectious Diseases (NIAID) 2,090
Early research (Phase 1)Ended earlyNCT03490162What this trial is testingSafety and Pharmacokinetics Study of DM1157 to Treat MalariaWho this might be right forMalaria National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableActive Not RecruitingNCT05676645What this trial is testingPharmacokinetics of Antimalarials in Breastfeeding Ugandan Mother-infant PairsWho this might be right forMalaria,Falciparum University of Liverpool 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06965244What this trial is testingLenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus ErythematosusWho this might be right forCutaneous Lupus Erythematosus (CLE) Assistance Publique - Hôpitaux de Paris 122
Testing effectiveness (Phase 2)Study completedNCT01047436What this trial is testingEfficacy of ArTiMist™ in ChildrenWho this might be right forFalciparum Malaria Proto Pharma Ltd 31
Early research (Phase 1)WithdrawnNCT04327310What this trial is testingClinical Study of Meplazumab to Treat With MalariaWho this might be right forMalaria (Plasmodium Falciparum) Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Testing effectiveness (Phase 2)Study completedNCT05829187What this trial is testingMomordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba RegencyWho this might be right forUncomplicated Plasmodium Falciparum Syamsudin Abdillah,Ph.D, Pharm D 36
Not applicableUnknownNCT04050566What this trial is testingMalaria Birth Cohort (MBC) in Agogo, GhanaWho this might be right forMalaria Bernhard Nocht Institute for Tropical Medicine 1,800
Post-approval studies (Phase 4)UnknownNCT01075945What this trial is testingDihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in SudanWho this might be right forMalaria University of Khartoum 140
Large-scale testing (Phase 3)Active Not RecruitingNCT06015737What this trial is testingA Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus ErythematosusWho this might be right forCutaneous Lupus Erythematosus AstraZeneca 306
Early research (Phase 1)Study completedNCT02614404What this trial is testingEffect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum MalariaWho this might be right forPlasmodium Falciparum Malaria HuLow 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07095309What this trial is testingSafety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal CancerWho this might be right forStage II/III Colon CancerBowel Cancer Metanoic Health Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT07235033What this trial is testingPlatform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)Who this might be right forUncomplicated Plasmodium Falciparum Malaria Novartis Pharmaceuticals 60
Not applicableStudy completedNCT04969185What this trial is testingAssociation Between Drug Levels, Malaria, and Antimalarial Resistance in the Setting of Seasonal Malaria ChemopreventionWho this might be right forMalaria,Falciparum University of California, San Francisco 310
Large-scale testing (Phase 3)Study completedNCT04334148What this trial is testingHealthcare Worker Exposure Response and Outcomes of HydroxychloroquineWho this might be right forCOVID-19 Adrian Hernandez 1,360
Very early researchUnknownNCT04340349What this trial is testingLow-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare ProfessionalsWho this might be right forHydroxychloroquineAntimalarialsEnzyme Inhibitors+1 more Instituto Nacional de Rehabilitacion 214
Early research (Phase 1)Ended earlyNCT00126971What this trial is testingChlorproguanil-Dapsone in Pregnant WomenWho this might be right forMalaria Centers for Disease Control and Prevention 132